On September 13th, the AI protein design platform company Molecular Heart announced that it has recently completed Series A financing. The amount of financing in this round reached several hundred million RMB, led by Sequoia Capital and Deep Venture Capital, with follow-up investments from SenseTime Capital and Jiu Yi Investment. Xu Jinbo, the founder of Molecular Heart and a computational biologist, stated that this round of financing will be used to further expand the diversified talent team, improve the AI protein basic large model, the AI protein optimization design platform MoleculeOS, and other biotechnology platforms, and accelerate the industrial landing and commercialization process of AI protein technology. (New Beijing News)
分子之心获数亿元人民币A轮融资 深创投等联合领投
Fenzi Zhi Xin (Molecular Heart) has received several hundred million yuan in Series A financing, led by Shenzhen Venture Capital and others.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Hot News
Updated